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ABSTRACT
Sox2 and Pax6 are transcription factors that direct
cell fate decision during neurogenesis, yet the mech-
anism behind how they cooperate on enhancer DNA
elements and regulate gene expression is unclear.
By systematically interrogating Sox2 and Pax6 inter-
action on minimal enhancer elements, we found that
cooperative DNA recognition relies on combinatorial
nucleotide switches and precisely spaced, but cryp-
tic composite DNA motifs. Surprisingly, all tested Sox
and Pax paralogs have the capacity to cooperate on
such enhancer elements. NMR and molecular mod-
eling reveal very few direct protein–protein interac-
tions between Sox2 and Pax6, suggesting that co-
operative binding is mediated by allosteric interac-
tions propagating through DNA structure. Further-
more, we detected and validated several novel sites
in the human genome targeted cooperatively by Sox2
and Pax6. Collectively, we demonstrate that Sox–
Pax partnerships have the potential to substantially
alter DNA target specificities and likely enable the
pleiotropic and context-specific action of these cell-
lineage specifiers.
INTRODUCTION
A primary goal of genomics and associated high-
throughput technologies is to decipher the cis-regulatory
code that determines when, where and how sets of genes are
expressed. This regulatory code directs biological processes
such as embryonic development and differentiation and
is the cause for phenotypic variance and evolutionary
innovation. Likewise, aberrations in this code can lead to
developmental abnormalities and/or disease progression.
The location of cis-regulatory ‘enhancer’ DNA sequences
that govern cellular identities is now known in many cell
types and lists of transcription factors (TFs) that bind
such enhancers and associated epigenetic signatures are
expanding rapidly (1,2). Enhancers are often composed
of clustered DNA elements with affinity for a set of TFs.
The architecture of an enhancer, that is, the sequence of
the DNA elements, their number, relative orientation and
spatial arrangement is thought to determine enhancer
activity (3,4). However, the process of how TFs in a
combinatorial fashion select enhancers to regulate gene
expression remains only superficially understood (5,6). TF
interactions are dynamic, transient and often depend on
cellular and genomic contexts (7). Both, complementary
protein interaction surfaces and the sequence of composite
DNA motifs mediate TF associations (8). So far, the struc-
tural architectures of very few TF–TF interactions have
been described at atomic resolution. Some well-studied
instances of heterodimeric TF partnerships include PPAR-
 -RXR- (9), Pax5-Ets (10), AR–FoxA1 (11), Sox2-Oct4
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(12,13) as well as Sox17-Oct4 (14–16). In some cases, TF
dimerization profoundly alters sequence specificities of the
binding partners as demonstrated by the association of the
Drosophila co-factor extradentrical (Exd) with Hox pro-
teins (17). The detection of such composite DNA-binding
sites is computationally challenging, as many conventional
motif discovery tools fail to take into account cooperative
interactions and allosteric effects that may occur between
interacting TFs.
To study how TFs team up to ‘read’ cis-regulatory in-
formation, we set out to biochemically dissect how mem-
bers of the Sry-related box (Sox) and pairedbox (Pax) fam-
ilies of TFs pair off to recognize enhancer sequences with
non-canonical ‘cryptic’ TF motif half-sites. All 20 Sox fac-
tors encoded in mouse and human genomes are composed
of a 79 amino acid L-shaped high-mobility group domain
(HMG) that mediates sequence-specific binding to the mi-
nor groove of the DNA leading to a pronounced kink (18–
20). The first functional target found to be regulated by
a Sox TF was the -crystallin gene within the presump-
tive lens ectoderm of the chicken embryo (21). A 30-bp
core enhancer termed DC5 located within the third intron
drives expression of -crystallin (22). After the discovery
that SoxB1 proteins, in particular Sox2, bind and activate
the DC5 enhancer, it took some time until the identity of a
collaborating factor initially termed EF3 could be uncov-
ered (23). Eventually, EF3 was found to be Pax6 (24). The
chicken DC5 sequence can also effectively drive reporter
gene expression in the Drosophila eye and cooperatively re-
cruit homologous fly TFs, suggesting a deep phylogenetic
conservation of the Sox2/Pax6 partnership and the regula-
tory circuit of lens specification (25). Pax6 had been known
for some time to be a key regulator of many aspects of devel-
opment, especially of neurogenesis (26). In addition, Pax6
initiates eye development as remarkably testified when it
could be shown that its ectopic expression can induce eye
structures in the legs of flies (27). The Pax gene family con-
sists of nine members in mammals, all of which are key
developmental TFs (28). Pax proteins are composed of a
bipartite 128 amino acid paired (PRD) DNA-binding do-
main (DBD) consisting of N-terminal PAI and C-terminal
RED subdomains binding the major groove of DNA and
additionally latched into the minor groove via an extended
linker (29,30). Some Pax TFs, including Pax6, contain an
additional homeodomain C-terminal of the paired domain
(31). This modular domain structure in Pax6 enables the ac-
commodation of diverse sets of binding sites by mechanisms
that can include an intricate interplay of the subdomains
and alternate utilization of subdomains for the recognition
of specific target sites (32–35).
In chicken embryos, Pax6 is initially broadly expressed
in the head ectoderm and becomes subsequently restricted
to the lens placode (24). Inductive signals derived from the
optic vesicle induce Sox2/Sox3 proteins in the lens pla-
code cells leading to the activation of -crystallin expres-
sion synergistically with Pax6 (24). A similar cooperation
between Sox2 and Pax6 has been implicated in autoregu-
lation of Sox2 by binding to an enhancer element termed
N3, which is well conserved across vertebrates (36). Both,
the N3 and DC5 enhancers are highly compact and pos-
sess canonical sox motifs, but highly degenerate pax mo-
tifs (36). Yet, this degeneracy is necessary for cooperative
binding of Sox2 and Pax6 and for effective activation of tar-
get gene expression (24,36). Mutations of sox or pax half-
sites as well as altered motif configurations abolished -
crystallin expression (24). In mouse and humans, both, Sox2
and Pax6, have been demonstrated to be key regulators of
neurogenesis (26,37–38). Sox2 and Pax6 are co-expressed
in neural stem cells (NSCs), the developing eye and several
other neuroectoderm-derived cells, providing ample oppor-
tunities for Sox2 and Pax6 to cooperatively bind to target
DNA sites in the human genome, reminiscent of the chicken
DC5 and N3 enhancers (Figure 1A). Additional Sox–Pax
partnerships including Sox10 and Pax3 have also been de-
scribed (39) and the co-expression of Sox and Pax family
members is observed in a plenitude of cell types (Figure 1B).
We therefore decided to interrogate the biochemical basis
for the cooperation of Sox and Pax TFs to (i) uncover the
sequence determinants for the cooperative interactions, (ii)
understand the biochemical and structural basis for the co-
operative formation of ternary complexes, (iii) ask if there is
a Sox–Pax partner code that determines target gene selec-
tion, (iv) assess whether mutations within Sox2 and Pax6
causative of congenital human eye disorders alter Sox2–
Pax6 cooperativity and (v) identify novel Sox/Pax target
site in the human genome that supports cooperative inter-
actions.
MATERIALS AND METHODS
Cloning, protein production and site-directed mutagenesis
Proteins encoding 79 amino acid HMG domains of mouse
Sox2, Sox4, Sox5, Sox15, Sox17 and an extended 109 amino
acid Sox2 were used with their amino acid sequences,
cloning and purification procedures as published elsewhere
(16). The extended 109 amino acid Sox2-HMG construct
was chosen for TROSY studies to detect potential inter-
actions in the extended C-terminal tail. This longer Sox2
construct was N15 isotope labeled, by growing Escherichia
coli cells in M9 minimal media containing isotope-labeled
ammonium chloride (Cambridge Isotope Laboratories) at
18◦C and purified using chromatographic procedures as de-
scribed previously (40). The following are the IMAGE IDs
of the Pax cDNA clones used in the study: Pax2 (IMAGE
clone ID: 40142579), Pax3 (IMAGE clone ID: 6518115),
Pax6 (IMAGE clone ID: 4504106), Pax8 (IMAGE clone
ID: 4239835) and Pax9 (IMAGE clone ID: 3707718). The
paired domain sequences were GATEWAY BP cloned (Life
Technologies) from their respective cDNA clones into the
pDONR221 vector using primers with attB1 sites (Supple-
mentary Table S1). The resulting pENTR constructs were
verified by sequencing and recombined into the pETG40A
and pETG20A destination vectors using the GATEWAYTM
technology (Life Technologies). Recombinant Pax proteins
were expressed and purified using a previously published
protocol (41). Expression vectors with point mutations in
Sox2-long (D123G) and Pax6 (R44Q and G36R) were gen-
erated using the QuikChange XL mutagenesis kit (Strata-
gene) according to manufacturer’s instructions (Supple-
mentary Table S1). The incorporation of point mutations
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Figure 1. Sox and Pax TFs are co-expressed in many cell types. (A) A scatterplot to compare SOX2 and PAX6 expression, highlighting co-expression in
several human cell lines. (B) A clustered heatmap of 5′ RNA CAGE counts was plotted using glbase with row normalization (44). Red and blue color
indicate high and low expression, respectively. Columns are 563 human FANTOM5 cell types. Rows are human SOX and PAX TFs.
DNA elements used
DNA sequences (Supplementary Table S2) labeled with 5-
carboxyfluorescein (FAM) or Cy5 were employed in the
study. Single-stranded oligos were purchased from Sigma
Proligo and cognate double-stranded DNA elements were
made by annealing the oligos in annealing buffer (20 mM
Tris–HCl, pH 8.0; 50 mM MgCl2; 50 mM KCl), heated to
95◦C for 5 min and subsequently ramping down at 1◦C/min
to 4◦C in a polymerase chain reaction block. To study the
effect of spacing between the sox and pax motifs, the fol-
lowing DC5 sequences with different spacing were used: -1
and -2 with reduced spacing and +1, +2, +3, +4 and +5
with increased spacing between the sox and pax half-sites.
For affinity measurements, a previously crystallized DNA
element (PDB ID: 6PAX) was used.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSAs) were per-
formed with 5′-FAM or 5′-Cy5-labeled cognate double-
stranded DNA elements (Supplementary Table S2). The
binding buffer contains 10 mM Tris–HCl pH 8.0, 0.1 mg/ml
bovine serum albumin, 50 M ZnCl2, 100 mM KCl, 10%
Ultrapure Glycerol, 0.10% IGEPAL CA-630 (octylphe-
noxypolyethoxyethanol) and 2 mM -mercaptoethanol.
For the differential assembly studies, typical binding re-
actions contain concentrations 100–300 nM of double-
stranded DNA (>> Kd) with varying concentrations of
Sox and Pax proteins. Protein concentrations were adjusted
such that an equilibrium is reached and the four microstates
are visible as distinctive bands on EMSA gels to allow re-
producible quantification. All binding reactions were in-
cubated for 1–2 h in the dark. Samples were loaded onto
1X Tris Glycine-PAGE gels (25 mM Tris pH 8.3; 192 mM
glycine) and electrophoresed at 200 or 300V for 30–120 min
at 4◦C. The gel was imaged using a Typhoon 9140 phos-
phor imaging scanner or a Typhoon FLA-7000 Phospho-
rImager (FUJIFILM) and the fluorescent intensities of the
free and bound DNA were quantified using the Image-
Quantz TL software. Cooperativity factors were calculated
using the formula  = (fdimer*ffreeDNA)/(fmonomer1*fmonomer2)
where fdimer is the fractional contribution of dimeric pro-
tein complexes on DNA (Sox/Pax/DNA), fmonomer1 and
fmonomer2 of monomeric (Sox/DNA or Pax/DNA) protein–
DNA complexes and ffreeDNA the fractional contribution of
unbound DNA in EMSA gel lanes. The derivation of the
formula has been described previously (16,42) and was fur-
ther discussed in (43).
Homology modeling of Sox2–Pax6
The models of the Sox2–Pax6–DNA ternary complexes
were build by superimposing B-DNA fragments corre-
sponding to the DC5, N3 and DC5con sequences on
the N-terminus and C-terminus of the structures of the
Sox2/DNA and Pax6/DNA complexes, 1GT0 (13) and
6PAX (30), respectively. In addition, the DNA molecules at
the C-terminus of the 1GT0 structure and at the N-terminus
of the 6PAX structure were superimposed, so as to reflect
the spacing between the Sox and Pax half-sites observed in
the DC5, N3 and DC5con sequences. The sequence of the
new DNA formed by concatenating the four DNA frag-
ments and removing the overlapping bases was mutated to
the correct DC5, N3, and DC5con sequences using chimera
(https://www.cgl.ucsf.edu/chimera/). The energy of the re-
sulting models of the ternary complexes was minimized in
AMBER (www.ambermd.org) using a stepwise procedure
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Bioinformatics analysis
Human FANTOM5 CAGE data (http://fantom.gsc.riken.
jp/5/) were downloaded and condensed into a single table
after averaging some duplicates and only the highest ex-
pressed promoter was kept for a given cell type. The clus-
tered heatmap was produced after row normalization us-
ing glbase (44). ChIP-Seq peaks for PAX6 in human NSCs
(45) or SOX2 neural progenitor cells (NPCs) (46) were
intersected. Motifs were created manually taking EMSA
data into account and co-bound SOX2/PAX6 sites were
searched for motif ‘words’ using glbase (44). To produce
genome plots using IGV, reads were re-mapped to the hu-
man genome (hg19).
Circular dichroism spectroscopy
The circular dichroism (CD) spectra were recorded on an
Chirascan CD Spectrometer (Applied Photophysics Ltd)
using a strain-free 10 mm x 1.0 mm rectangular cuvette
using the following parameters: bandwidth, 1 nm; spectral
range, 230–360 nm; step-size, 1 nm; time-pep-point, 0.5 s.
In total, 1.6 M dsDNA and 5 M Pax6-PRD were mixed
in 50 mM phosphate buffer, pH 8.0. Three repeat measure-
ments were averaged.
Nuclear magnetic resonance experiments, data acquisition
and processing
Nuclear magnetic resonance (NMR) experiments were
performed using Bruker AVANCE II 600 and 700 MHz
NMR spectrometers equipped with a standard TCI (Triple
resonance cryoprobe) cryoprobe. The spectra were collected
at 298 K. A series of 2D [15N, 1H]-TROSY experiments was
utilized to monitor the chemical shift perturbations (CSP)
of the 15N, 1H spins. The chemical shifts were referenced
directly (1H) relative to 4,4-dimethyl-4-silapentane-1-
sulfonic acid (DSS). The spectral analysis was performed
using CARA (47). For NMR experiments, a 31bp DC5
element was used with the following forward and com-
plementary reverse strand sequence respectively (DC5 f:
5’-TTCATTGTTGTTGCTCACCTACCATGGATCC-3’;
DC5 r: 5’-GGATCCATGGTAGGTGAGCAACAAC
AATGAA -3’).The 31bp DC5 DNA element was dissolved
in the following NMR buffer (50 mM K2HPO4/KH2PO4,
100 mM NaCl buffer, pH 7.0). The buffer components are
kept consistent for all NMR experiments unless otherwise
stated. The pH of the solutions was adjusted to 7.0 using
NaOH. The final concentration of the DC5 stock solution
was determined using NanoDrop at 260 nm. We have previ-
ously recorded 3D spectra of 1H, C13 and N15 labeled Sox2
(109 amino acid long) and assigned residues to the majority
of resonances (40). The N15 labeled Sox2-HMG was added
carefully to the DNA element (31-mer) in a stepwise man-
ner to achieve final molar ratios of Sox2/DNA of 0.25, 0.5,
0.75 and 1.0, with the final DNA concentration of 0.2 mM.
The 1D spectrum of the 31mer-DNA alone was used as a
reference to observe perturbations inflicted by the binding
of proteins to the DNA. A 2D [15N, 1H]-TROSY spectrum
was collected at each titration point. The weighted CSP for
backbone 15N and 1HN resonances were calculated by the
equation (48):  = [(HN)2 + (0.1N)2]0.5.
RESULTS
Pax motif degeneracy is necessary for the cooperativity of
Sox2 and Pax6
Sox2 and Pax6 are co-expressed in a number of human cell
types, namely fetal eyes, NSCs, cerebellum and hippocam-
pus (Figure 1A). A large number of other Sox and Pax fam-
ily members are co-expressed in other cell types (Figure 1B).
Given that Sox2 and Pax6 have been shown to act as ‘master
regulators’ of pluripotency and neurogenesis, we surmised
that Sox–Pax cooperativity is key for cell fate decisions. We
previously set up quantitative EMSAs to estimate cooper-
ativity factors (), i.e. the ratios of the equilibrium bind-
ing constants of dimeric versus monomeric complexes of
TFs binding to composite DNA enhancer elements (16,42).
Three minimal native sequences extracted from the DC5
(24), N3 (36) and LE9 (49) enhancer elements were cho-
sen to study the interaction between the Sox2-HMG and
Pax6-PRD domains (henceforth termed Sox2 and Pax6).
In addition, we used a modified sequence of the DC5 ele-
ment, DC5con (24) where the native low-affinity pax half-
site is replaced with a high-affinity half-site as determined
by SELEX (32,50) (Figure 2A). In agreement with previ-
ous studies (24), Sox2 and Pax6 were found to form ternary
complexes on both the DC5 and N3 enhancer elements
(Figure 2B). By contrast, using the LE9 enhancer (49), we
observed competitive binding (Figure 2B). When the pax
half-site of the wild-type DC5 element was replaced with
DC5con, ternary complex formation was markedly weak-
ened as evident from the observation that Sox2–DNA and
Pax6–DNA complexes are still prominently visible in ad-
dition to the ternary complex suggesting ineffective com-
plex formation (Figure 2B). To understand the structural
basis for the cooperativity, we generated structural mod-
els of Sox2–Pax6 complexes on DC5con, DC5 and N3 en-
hancer sequences (Figure 2C). The models show that Sox2
and Pax6 do not interact directly through the globular core
of their DBDs. However, they may form some protein–
protein interactions through the C-terminal tail of Sox2
and communicate through DNA-mediated allostery. In-
deed, when we calculated the cooperativity factor, we ob-
tained values between 20 and 50 for Sox2–Pax6 coopera-
tion on DC5 and N3 elements, respectively (Figure 2D).
However, on the DC5con element, we measured additive
binding ( ∼ 1), demonstrating that degenerated pax half-
sites as found in the native DC5 and N3 elements are es-
sential for the cooperative interaction of Sox2 and Pax6.
Next we incubated Sox2 and Pax6 simultaneously with Cy5-
labeled DC5 and FAM-labeled DC5con to evaluate the dis-
tribution of Sox2 and Pax6 on alternative target sites. Bi-
nary Pax6–DNA complexes are detectable at low Pax6 con-
centrations on the high-affinity DC5con element. By con-
trast, ternary Sox2–Pax6–DNA complexes predominate on
the high-cooperativity DC5 element and binary Pax6–DNA
complexes are barely visible (Figure 2E). This suggests that
in a cellular environment where large numbers of DNA mo-
tifs compete for TF binding, Pax6 is effectively recruited to
its consensus binding site. However, activation-competent
ternary Sox2–Pax6 complexes are more effectively recruited
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Figure 2. Pax motif degeneracy is necessary for cooperative ternary complex assembly. (A) A SELEX-derived Pax6 PWM (50) was downloaded from
JASPAR and is displayed above DC5 (21) and N3 (36) enhancer sequences. The residues introduced into the DC5con element to generate a pax site
resembling the SELEX consensus are shown in red. (B) EMSAs to monitor the formation of ternary Sox2–Pax6–DNA complexes on DC5con, LE9, DC5
and N3 elements. The cartoon on the left depicts different complexes obtained during EMSA. (C) A structural model of Sox2–Pax6–DNA complex is
shown. The DNA is shown as gray surface. The Sox2-HMG derived from PDB-ID 1GT0(13)is shown in blue and the Pax6-PRD (PDB-ID 6PAX (30))
in orange. Pax6-PRD subdomains (DBD1 and DBD2) and the linker are marked. (D) Cooperativity factors are calculated after quantifying the four
possible microstates seen on EMSA gels (free DNA, Sox2.DNA, Pax6.DNA and Sox2.Pax6.DNA) using established procedures (16) and are shown as
boxplots using data from 9–13 replicate experiments. Values for the LE9 enhancer could not be reliably determined as the ternary complex bands were
barely detectable. (E) EMSAs were performed by simultaneously incubating Sox2 and Pax6 with differently labeled DC5 and DC5con DNA. Gels are
shown after scanning using Cy5 (670 nm band-pass emission filter) or FAM (520nm band-pass emission filter) settings on a Typhoon phosphorimager.
In total, 300 nM of each Cy5-DC5 and FAM-DC5con were used along with 100 nM Pax6 (FAM and cy5 control, lanes 3,4,7,8) or 300 nM Pax6 (lanes
10–18). Moreover, 100 nM Sox2–109aa was used in the Cy5 and FAM control reactions (lanes 2,4,6,8) or with increasing concentrations from 25 to 600
nM (lanes 11–18).
The composite Sox2–Pax6-binding site is compact and
rigidly spaced
Next we studied the effect of inter-motif distances on the
efficiency for Sox2–Pax6 dimerization. The 2, 4 and 10 base
pair spacers have previously been found to abrogate Sox2–
Pax6 cooperation on the DC5 element (24). Here we ex-
tended these studies by interrogating the effect of motif
spacing from -2 to 5 base pairs at 1-bp intervals (Figure 3A
and B). We observed that even subtle changes to the spac-
ing between the sox and pax half-sites had profound effects
on complex formation (Figure 3A–C). Ternary complexes
are barely visible and cooperativity factors turn negative
upon reducing the spacing between the motifs by 1 and 2
bp. This indicates competitive binding possibly due to steric
hindrance when the proteins are brought too close to each
other. Upon increasing the spacing (+1,+2,+3 & +5), the
cooperativity factor markedly decreases (∼30-fold) reminis-
cent of the additive binding seen on the DC5con element
(Figure 3B and C). The +4bp spacer is an exception as it
retains a weak albeit still strongly reduced cooperativity as
compared to the other non-native spacers (Figure 3C). Col-
lectively, these experiments highlight that precise motif jux-
taposition is necessary for the formation of a cooperative
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Figure 3. Effect of motif spacing and sequence features on Sox2–Pax6 cooperativity. (A,B) EMSAs using DC5 enhancer elements with systematically
altered spacing between sox (blue) and pax (orange) binding elements. (C) Cooperativity factor measurements revealed a drop in the cooperativity by at
least an order of magnitude for all artificial spacers as compared to the native element. (D) DC5 sequences were sequentially converted into DC5con-like
sequences corresponding to the Pax6 consensus and cooperativity factors were determined (E). Whiskers in barplots indicate standard deviations. (F)
Interactions between Asn14 and Gly15 and DC5con-like sequence as seen in the 6pax crystal structure and the DC5con model and perturbations of these
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enhancer architecture lead to drastic reductions in ternary
complex assembly, suggesting rigid spatial constraints for
the assembly of the complex.
Nucleotide switches act in concert to enable cooperative
Sox2–Pax6 interaction
Next we aimed to identify the sequence features that convert
the high-cooperativity DC5 element that facilitates dimer
formation of Sox2 and Pax6, into a site detrimental to their
co-recruitment. The pwm (position weight matrix) of the
ideal Pax6 motif (JASPAR ID: MA0069.1) derived from
SELEX assays (50) identifies four nucleotide positions with
high information content that deviate from the degener-
ate pax half-site in the native DC5 and N3 elements (Fig-
ure 3D). These positions will be referred to as T3, G8, C9
and T11 (Figure 3D). In order to dissect the role of these
four key nucleotide positions in the DC5 element, we se-
quentially converted the degenerate pax half-site in the na-
tive DC5 element to resemble the high-affinity DC5con pax
half-site (Figure 3D). Interestingly, point mutations to any
of the four key nucleotide positions in the DC5 element did
not decrease cooperative binding (Figure 3E). In fact, some
point mutations even led to an elevation of the cooperativ-
ity, including the G8 and C9 positions (Figure 3E). How-
ever, a G8C9 di-nucleotide mutation substantially lowered
the cooperative binding (Figure 3E). The tri-nucleotide mu-
tations T3G8C9 and G8C9T11 further enhanced this ef-
fect and successively approached a cooperativity reminis-
cent of DC5con (Figures 2C and 3E). This suggests that the
nucleotide positions do not linearly contribute to the com-
plex formation but are interdependent. Our models of the
three ternary complexes revealed that the interactions be-
tween the Pax6-PRD around nucleotides G8, C9 and T11
were found to be most optimal in DC5con (Figure 3F). The
less optimal configuration of Pax6 bound to the DC5 (Fig-
ure 3G) and N3 (Figure 3H) sequences may be further im-
proved by small reorientations of the Pax DBDs that may
lead to configurations enhancing cooperativity with Sox2.
Such configurations may also be triggered by changes in
DNA structure induced by the presence of Sox2. However,
it cannot be ruled out that, the DC5 and N3 sequences may
induce an assembly of Pax6 in a conformation completely
different from the one in our models, which resemble that
in the structure of a previously solved Pax6/DNA com-
plex (PDB: 6PAX) (30). Alternatively, the orientation of
Pax6 could change to accommodate the DC5 sequence. In-
deed, when we inspected the reverse-complement of the pax
consensus sequence (con’) and of the consensus sequence
co-crystallized with Pax6 (30) (6pax-rev), we observed a
good agreement with DC5 (Figure 4A). In particular, nu-
cleotides 3, 9 and 11 found to be critical for the ‘cooperativ-
ity switch’ (Figure 3) align perfectly between DC5 and 6pax-
rev. We therefore decided to test if the DC5 element encodes
a cryptic pax consensus and mediates cooperative binding
through a changed orientation of Pax6. To this end, we
constructed DC5con’-1 and DC5con’-2 sequences contain-
ing a reverse complement of the sequence found in the 6pax
crystal structure spaced appropriately so that the key nu-
cleotides 3, 9 and 11 align with wild-type DC5 (Figure 4A).
Structural modeling (refer Material and methods, Homol-
ogy modelling section) suggests that Sox2 and Pax6 could
co-bind such sequences (Figure 4B). However, EMSAs re-
vealed that complex formation is inefficient on both tested
DC5con’ sequences and monomeric complexes predominate
(Figure 4C–F). Moreover, when the three nucleotides 3, 9
and 11 that match DC5 in DC5con’ but not in DC5con
were mutated in DC5, the cooperativity remained high (Fig-
ure 4G and H). Collectively, these experiments suggest that
Pax6 is unlikely to bind DC5 in a ‘flipped’ conformation
(Figure 4B).
Cooperative binding to specific enhancer sequences is a con-
served trait in the Sox and Pax protein families
We previously studied cooperative binding of Sox and Oct
protein families to identify signature enhancer sequences.
We observed a partner code with distinctive Sox-Oct com-
binations binding specific composite sox-oct DNA motifs
(16). Selective binding relies on certain amino acids of the
Sox HMG and interchanging these residues between Sox
factors swaps their ability to dimerize with Oct4 on spe-
cific composite motifs and to direct cell fate decisions dur-
ing pluripotency or endoderm induction (14–15,51). To test
whether a similar partner code exists for Sox–Pax interac-
tions, we purified representative members of the Sox and
Pax families and conducted quantitative cooperative mea-
surements. First we asked whether Pax6 selectively cooper-
ates with Sox2 or if it also teams up with other Sox factors.
To this end, we selected members from several subgroups
of the 20-member Sox family. Specifically, we chose Sox4
of the SoxC group, Sox5 of the SoxD group, Sox17 of the
SoxF group and Sox15 of the SoxG group and tested them
alongside the SoxB1 group member Sox2. We found that
Sox2, Sox4, Sox5, Sox15 and Sox17 cooperatively bound
with Pax6 to DC5 and N3 enhancer elements in an indistin-
guishable fashion (Figure 5A and B). Next we conducted
inverse experiments and compared the cooperative binding
of Sox2 with Pax2, Pax3, Pax5, Pax6, Pax8 and Pax9 to the
DC5 sequence. There are some sequence variations within
the PRD paralogs, some of which were previously found to
be critical for discriminative DNA binding (32) (Figure 5C).
Nevertheless, we found that all Pax family members can co-
operatively pair-off with Sox2 on the DC5 element, whereas
the cooperativity is abolished on the DC5con element (Fig-
ure 5D and E). This suggests that all Pax PRDs possess bio-
chemical features conducive for the cooperation with Sox2
on specific enhancers with cryptic Pax6-binding sequences.
Therefore, cooperativity on DC5-like sequences is a bio-
chemical trait conserved within Sox and Pax TF families.
As Sox and Pax paralogs are co-expressed in diverse cell
types (Figure 1B), it can be envisaged that there are ample
opportunities for members of the two families to interact.
However, the propensity to cooperatively recognize DC5-
like sequence in vitro does not imperatively suggest that all
co-expressed Sox/Pax pairs combinatorially regulate gene
expression and further studies are necessary to establish
new functional Sox/Pax partnerships. First, it has to be as-
sessed whether co-expressed Sox/Pax pairs indeed co-bind
enhancer sequences. Second, it has to be tested whether the
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Figure 4. Sox2 and Pax6 do not cooperate on DC5con’ elements encoding a flipped pax consensus. (A) The sequence logo of forward and reverse pax
consensus motifs is aligned with sequences of DC5, DC5con, DC5con’ and forward and reverse sequences co-crystallized with Pax6 (PDB-ID 6pax).
Switch nucleotides (Figure 3) are marked with asterisks. The nucleotides 3, 9 and 11 found to be part of the ‘cooperativity switch’ are identical between
DC5 and DC5con’. (B) Structural model of a Sox2/Pax6 complex on the DC5con’ sequence with Pax6 in a hypothetical flipped conformation. EMSAs to
study the cooperativity of Sox2 and Pax6 on DC5 (C), DC5con (D), DC5con’-1 (E), DC5con’-2 (F) and mutations to make the DC5 sequence more closely
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Figure 5. The potential to cooperate is conserved in the Sox and Pax TF families. Formation of ternary complexes between Pax6 and long (109aa) and
short (79aa) versions of the Sox2-HMG and paralogous mouse Sox HMGs (79aa) of Sox4, Sox5, Sox17 and Sox15 on (A) DC5 and (B) N3 elements.
Note that 79 amino acid Sox-HMG versions co-migrate with the Pax6-PRD bound to DNA, whereas the 109aa version migrates as distinctive band. (C)
Multiple sequence alignment of mouse Pax paralogs marking secondary structure elements above the alignment. Numbering corresponds to human PAX6
uniprot-ID P26367 for easier reference to eye diseases mutations. Red bars mark the Asn17 and Gly18 di-peptide binding to the di-nucleotide switch and
residues previously shown to provide discriminatory sequence recognition between Pax6 and Pax5 (32). (D and E) The Sox2-HMG (109aa) was assessed
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DNA binding of clinically relevant Sox2 and Pax6 mutant
proteins
Several eye diseases including blindness and aniridia are
caused by heterozygous Pax6 mutations, several of which
map to the paired domain (52–56). Likewise, Sox2 muta-
tions were recently reported to be associated with visual dis-
orders (57,58). As the biochemical consequences that lead
to disease are not understood for most of those mutations,
we tested whether DNA binding or protein-partnerships
are perturbed. One selected mutation was found in a four-
generation family proband in Australia that has bilateral
anophthalmia and several milder visual system anomalies
like typical optic fissure coloboma (57). A novel D123G
mutation in the C-terminal tail following the Sox2 HMG
domain was detected in this family that was attributed to
anophthalmia (57). Since D123G maps to a region near
the hypothetical binding interface between Sox2 and Pax6
(Figure 6A), we examined whether this mutation alters the
propensity to a form ternary complex. However, we could
not detect any changes in complex formation compared to
the wild-type Sox2 (Figure 6B). Similarly, co-binding with
Oct4 on the Fgf4 enhancer element was also not altered for
the Sox2D123G mutation (Supplementary Figure S1). Next
we selected the Pax6 missense mutations G36R and R44Q
previously detected in aniridia patients (59,60). In our struc-
tural models, those mutations are in proximity to the pu-
tative Sox–Pax contact interface (Figure 6C). We therefore
wanted to examine whether these two mutations could al-
ter cooperativity with Sox2. We observed that G36R and
R44Q markedly reduced affinity for DNA binding (Figure
6D). However, Pax6R44Q did not affect the cooperativity
with Sox2 on the DC5 element (Figure 6E). The cooper-
ativity factor for Pax6G36R could not be determined due
to the low overall affinity for DNA. Therefore, diminished
DNA binding of the Pax6 protein likely causes the devel-
opment of aniridia in Pax6R44Q and Pax6G36R patients.
Consistently, in co-crystal structures of the highly homolo-
gous Drosophila Prd protein bound to DNA it can be seen
that the residue homologous to R44Q is in contact with the
sugar phosphate backbone of DNA (29).
NMR and modeling imply a DNA-mediated allosteric mech-
anism for Sox2–Pax6 interaction
The mechanism of the cooperative recognition of DC5
DNA by Sox2 and Pax6 cannot be straightforwardly mod-
eled based on available experimental structures. Our bio-
chemical assays and structural models suggest that in par-
ticular the Pax6-PRD might adopt different conformations
compared to the configuration seen when bound to its high-
affinity element (29,30). Such conformational versatility has
been described for the POU family that also contains a bi-
partite DBD. POU members were found to adopt strik-
ingly different tertiary structure and altered stoichiome-
try depending on the sequence of the bound DNA ele-
ment (61–63). To define the protein–protein interaction in-
terface between Sox2 and Pax6, we performed NMR stud-
ies. First, we measured 1D 1H spectra of Sox2 alone, DC5,
Sox2-DC5 and ternary Sox2–Pax6–DC5 complexes (Figure
7A). DC5 in complex with Sox2 showed significantly more
dispersed imino proton resonances at the region between
12 and 14.5 ppm indicating bending of the DNA induced
by Sox2 (Figure 7A). In addition, we observed significant
chemical shifts and differential line broadening of the 1H
doublet signals from the indole groups of the Sox2 trypto-
phan residues W13 and W41 in the 10–11 ppm region upon
DNA addition, indicating a significant increase in molec-
ular weight and effective complex formation. Addition of
Pax6 to the Sox2–DC5 binary complex enhances differen-
tial line broadening in the 1H doublets of W13 and W41, in-
dicating further molecular weight increase upon formation
of the ternary complex (Figure 7A). However, binding of
Pax6 to the Sox2–DC5 complex results only in relatively mi-
nor shifts of both Sox2 tryptophan 15N and 1H resonances
(Figure 7B). Yet, the 1H resonance corresponding to W41
(H) is observed to attenuate considerably while W13 (H)
remains stable (Figure 7A and B). These results suggest that
incorporation of Pax6 into a ternary complex might affect
the conformational dynamics of Sox2 and possibly affects
how Sox2 bends DNA.
Comparative 15N/1H Sox2 spectra before and after DC5
addition revealed CSP and conformational-exchange in-
duced line broadening for many peaks (Figure 8A and
B). By mapping CSPs to our models of Sox2/DNA and
Sox2/Pax6/DNA complexes (13), we found that residues
undergoing CSPs are not restricted to the DNA contact
interface, suggesting global structural rearrangements of
Sox2 upon DNA binding (Figure 8C and D). The largest
CSPs (> 0.1 ppm) observed are for K4, G16, K20, E24,
N25, S34, K42, L43, A56 and K65 (Figure 8E). Residues
that experience line broadening are predominantly located
in the hydrophobic core of the protein. When Pax6 is added
to form the Sox2–Pax6–DC5 ternary complex, only a few
additional CSPs were observed in Sox2 (Figure 8B, D and
E: K4, Q23, T80, L81). Yet, Pax6 addition leads to a con-
siderable attenuation of peak intensity in the region of the
major wing (helices 1 and 2), indicating that Pax6 may pri-
marily affect the dynamics and stability of the Sox2–DC5
interactions rather than directly binding to Sox2 and al-
tering its conformation. Notable exceptions are R15 and
R19 that experience an increase in the peak intensity af-
ter Pax6 addition potentially indicating more favorable elec-
trostatic interactions for these residues in the ternary com-
plex. CD measurements showed that the DNA peak at
280 nm is slightly shifted in DC5 as compared to DC5con
DNA (Figure 8F and G). Likewise in silico predictions
(GBShape (64) ) of the minor groove width suggest an al-
tered pattern of groove compressions over the pax half-site
(Figure 8H). Those structural differences could affect the
propensity of the respective DNA sequences to mediate the
co-recruitment of Sox2 and Pax6. Collectively, our data sug-
gest that Sox2–Pax6 cooperation on DC5-like sequences
is not mediated by complementary protein–protein inter-
actions but rather by an allosteric, DNA-mediated mech-
anism that relies on a subtly adjusted DNA structure in
agreement with our models of the ternary complexes. Col-
lectively, our data suggest that, DC5-like sequences support
a predominantly DNA-mediated mechanism of cooperativ-
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Figure 6. Eye disease mutations and Sox2–Pax6 interactions. (A) Structural model of a hypothetical Sox2–Pax6 complex. The D123G mutation (57) maps
to a region in the C-terminal tail just off the portion visible in the crystal structure (indicated with arrow and dashed line). A domain plot indicating
the Sox2 constructs used for cooperativity measurements are shown below. (B) A barplot comparing cooperativity factors for the interaction of Sox2
versus Sox2D123G with Pax6 on DC5 and N3 DNA elements. Whiskers indicate standard deviations from seven to nine measurements. (C) Location
of two Pax6 mutations R44Q and G36R within the Pax6 PRD. (D) The missense mutations lower the affinity for DNA as compared to the wild-type
PRD on a consensus Pax6-binding element (Pax6 xtal, Supplementary Table S1). (E) Cooperativity measurements for Pax6 and Pax6R44Q on DC5 and
DC5con elements show that the R44Q mutation does not abolish cooperative complex formation. Whiskers indicate standard deviations from five to six
measurements.
Identification of cryptic SOX2/PAX6 cooperativity loci in
human NSC enhancers
The chicken DC5 and N3 sequences support cooperative
and functionally important Sox2/Pax6 interactions. How-
ever, the cooperative interaction of SOX2 and PAX6 on re-
lated sequences has so far not been reported for human
cells. We hypothesized that SOX2 and PAX6 also coop-
erate on DC5-like sequences during human neurogenesis.
To test this hypothesis, we took advantage of recently pub-
lished ChIPseq studies of PAX6 in human NSCs (referred
to as neuroepithelial cells by the authors) (45) and SOX2
ChIPseq data from NPCs (46). While both cell types are
not identical, they constitute the most closely related hu-
man cell types for which ChIPseq data are presently avail-
able. After intersection, we obtained 2353 regions co-bound
by PAX6 and SOX2 (Figure 9A). De novo motif searches re-
vealed that more than 30% of the shared loci contain con-
sensus sox motifs (Figure 9B). However, known pax motifs
are only present in ∼3% of the putative NSC enhancers, sug-
gesting that the vast majority of Pax6-targeted sites does
not rely on high-affinity pax motifs in vivo. As only the
N3 and DC5 sequences are known to support Sox2/Pax6
cooperation, there is no position-weight matrix or related
binding models for capturing cryptic pax half-sites as ob-
served in the DC5 or N3 enhancer. We therefore manu-
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Figure 7. Assembling a stable ternary complex for NMR studies. (A) 1D
1H spectra with increasing stoichiometry of Sox2-HMG in complex with
DC5, from bottom to top (Sox2 to DC5 ratios at 0.25, 0.5, 1.0, 1.5) as well
as a Sox2–Pax6–DC5 ternary complex. (B) The tryptophan indole spectral
region of 2D [15N,1H]-TROSY spectra. The chemical shift changes in the
tryptophan Ne1/He1 side chain groups are indicated by arrows for Sox2
only (blue) in the presence of DC5 (red) and the ternary Sox2–DC5–Pax6
complex (green).
‘words’ based on our EMSA results. We used these motifs
to search the 2353 NSC enhancers and detected 20 DC5-
like sequences, most of which exhibit a strong ChIPseq sig-
nal indicative of effective Pax6 binding (Figure 9C). We se-
lected eight of those sequences for EMSA validation (Fig-
ure 9D). All tested sequences showed ternary Sox2–Pax6–
DNA complexes illustrating that high-affinity pax motifs
are not required for complex formation (Figure 9E). More-
over, several enhancer sequences supported the coopera-
tive recruitment of Sox2 and Pax6 reminiscent of DC5 and
N3 enhancer elements (Figure 9E). In conclusion, the part-
nership between SOX2 and PAX6 on cryptic DC5-like se-
quences also occurs during human neurogenesis and possi-
bly underlies the combinatorial action of those TFs during
cell fate determination.
DISCUSSION
The present work takes advantage of the seminal studies by
Kamachi, Kondoh and co-workers revealing that Sox2 and
Pax6 cooperate on the 30 bp DC5 core enhancer to acti-
vate the -crystallin gene in chicken eyes (21–22,24). Their
work suggested a striking example of TF association on
composite DNA elements despite the lack of a high-affinity
consensus sequence for Pax6. Therefore, the DC5 eye en-
hancer provided a paradigm, highlighting the intricacies of
how TFs pair off to read the regulatory code underlying de-
velopmental programs (21,24). The functional studies and
the intricate behavior in qualitative binding assays encour-
aged us to quantitatively dissect Sox2 and Pax6 coopera-
tivity and the molecular basis for this partnership. Collec-
tively, we found that (i) cooperativity critically relies on de-
generate pax sites and that consensus sites abrogate ternary
complex formation; (ii) highly constrained spacing arrange-
ments of sox and pax half-sites are critical for cooperative
binding; (iii) key nucleotide switch positions in the degen-
erate pax half-sites act in concert to mediate cooperative
assembly of Sox2 and Pax6; (iv) the mechanism of coop-
erative binding is evolutionary conserved within Sox and
Pax families and, finally, (v) direct protein–protein interac-
tions between Sox2 and Pax6 are sparse if present at all.
Overall, these results suggest that stable Sox–Pax interac-
tions rely on specific DNA sequences and not complemen-
tary protein-interaction interfaces. To rationalize the switch
from a high-affinity DC5con-like to a high-cooperativity
DC5-like binding configuration, we inspected the molecu-
lar environment of switch nucleotides in structural models.
The ‘T3G8C9′ nucleotides are major features triggering the
switch. T3 contacts Asn50 through van der Waals interac-
tions (Figure 3F–H). G8 is directly contacted by Asn17 via
hydrogen bond, G9′ (the base complementary to C9) is con-
tacted by Gly18 through hydrogen bonds and finally T11 is
contacted by the linker region residue Gly72 (30). Replac-
ing G9′ by a DC5-like A9′ suggests a detrimental interac-
tion with Gly18 as the N2 primary amine hydrogen donor
is lost. Likewise, replacing G8 by C8 could de-stabilize the
side chain O of Asn-17 as it loses the H-bond donor amine
at the position (Figure 3F, G and H). Replacing T11 to C (as
in DC5) or G (as in N3) also leads to a less protein–DNA in-
teractions in the region of the Pax6 linker, which was previ-
ously shown to be crucial for DNA binding (30). Hence, we
surmise that on the high-affinity pax half-site, the ‘G8C9′
nucleotide in the DC5con sequence tightly tethers Pax6 to
the minor groove of the DNA in a constrained configura-
tion, in a manner that is independent of the influence of
an adjacent Sox2-binding site. Hence, Sox2-Pax6 dimers are
formed in an additive fashion. By contrast, a loss of this in-
teraction by mutating G8C9 removes constraints and allows
the Pax6 protein to adopt a conformation in favor of coop-
erative binding. The cooperative assembly on DC5-like se-
quences is likely facilitated by an allosteric, DNA-mediated
mechanism. While structural models provide a rudimentary
framework, the overall effect of these mutations in the de-
generate pax half-sites on the binding topology and con-
formation of Pax6 is still ambiguous and will be made clear
only when atomic resolution structures of Pax6 on DC5-like
sequences become available (41).
A recent study on Sox2 and Pax6 cooperativity used plas-
mon resonance and gold nanoparticles tethered to the end
of DC5 and DC5con sequences. While Sox2 alone induced
indistinguishable bends, it was reported that the DC5 is
more markedly deformed by Sox2–Pax6 dimers than the
DC5con element (65). Apparently, Sox2–Pax6 binding in-
duces structural changes to DNA in a sequence-dependent
manner. Another study employed single molecule atomic
force microscopy and reported cooperative binding as well
as the requirement for Sox2-induced bending for effective
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Figure 8. Sox2–DC5 and Sox2–Pax6–DC5 interactions analyzed by [15N,1H]-TROSY. (A) Superposition of 2D [15N,1H]-TROSY spectra of free Sox2
(black) and Sox2–DC5 (orange) and (B) Sox2–DC5 (orange) and Sox2–Pax6–DC5 (green) on the right panel. The spectra are acquired at the stoichiometric
ratios of 1:1.2 (Sox2–DC5) and 1:1.2:1 (Sox2–DC5–PAX6). (C and D) The Sox2 CSP weighted as  = [(1HN)2 + (0.1N)2]−1/2 are mapped onto the
Sox2-HMG in Sox2–DC5 (C) and Sox2–Pax6–DC5 models (D). (E) CSP of Sox2 in binary (orange) and ternary (green) complexes relative to free Sox2
versus the Sox2 amino acid sequence (numbered according to Sox2: PDB 1GT0 (13)). ‘D’ denotes DNA-binding residues. The lower panel shows weighted
Sox2 CSP of the binary versus ternary complexes. CD spectra recorded of Pax6 (F) and DNA (G). The arrow highlights the slightly shifted peak at 280
nm. (H) The width of the minor grooves in DC5 and DC5con as estimated by GBshape (64) (http://rohsdb.cmb.usc.edu/GBshape/).
with a model where DNA deformations supportive of coop-
erative complex formation occur on the DC5-like sequence
but not on DC5con-like sequences. However, a R75E mu-
tation mapping to the C-terminal extension of the Sox2-
HMG was demonstrated to abrogate Sox2–Pax6 dimeriza-
tion on DC5 (13). As this site interacts with Oct1 in the crys-
tal structure of the Sox2/Oct1/Fgf4 ternary complex, the
authors reasoned that this residue directly interacts with the
Pax6-PRD as well (13). However, in our NMR experiments
R75 could not be assigned due to pronounced line broad-
ening. From our structural models, we observed that R75
is in proximity to the DNA backbone and is not far apart
from the Pax6 PRD domain (Figure 5C). As our models








ong Kong user on 15 February 2019
1526 Nucleic Acids Research, 2015, Vol. 43, No. 3
Figure 9. Identification of loci supporting Sox2/Pax6 dimerization during human neurogenesis. (A) Scheme illustrating the selection of candidate DC5-like
sequences bound by PAX6 and SOX2 in human cells. (B) De novo motifs recovered using homer (http://homer.salk.edu/homer/chipseq/) in SOX2/PAX6 co-
bound loci. (C) Genome plots spanning 100 kb (ACACA: acetyl-CoA carboxylase Alpha, EFNA5: ephrin-A5, UPP2 - uridine phosphorylase 2) or 184 kb
(FGFR2: fibroblast growth factor receptor 2) are shown for selected candidate loci predicted to recruit SOX2/PAX6 dimers in a cooperative fashion. Black
bars indicate binding sites with DC5-like sequences used for EMSA validation. Binding site definitions were used as reported in the original publications
(45,46). (D) Sequences of novel DC5-like composite motifs short-listed for EMSA validation. (E) EMSAs showing effectively formed SOX2/PAX6 dimers
on newly identified NSC enhancer sequences.
tion of the ternary complexes needs to adapt to promote
Sox–Pax cooperativity, it is possible that a glutamate at po-
sition 75 interferes with the adaptation. However, we can-
not exclude that there might be some direct protein–protein
interactions that do not lead to obvious chemical shifts in
2D-NMR. Yet, we surmise that a DNA-mediated mecha-
nism is the main driver for the cooperative co-recruitment
of Sox2–Pax6 to DC5-like sequences.
Genomic studies also point toward the versatile mech-
anism by which Pax6 engages chromatin. Analysis of the
genome-wide binding of Pax6 by ChIPseq in human neu-
roectoderm revealed that less than 3% of the binding sites
contain consensus pax motifs (Figure 9B). However, sox
motifs were frequently found in proximity to Pax6-binding
sites (Figure 9B). Moreover, missense mutations in either
the PAI or RED subdomains differentially affect the ge-
nomic target selection of Pax6 (35). Apparently, some en-
hancers more strongly rely on PAI and others on RED for
efficient genomic targeting. This suggests that Pax proteins
employ different binding modes to recognize alternative sets
of target sequences. Such differences could account for dif-
ferential TF partner recruitment and profoundly affect the
regulatory outcome of the binding event.
The striking observation that partner factors prefer se-
quences that are very different from their consensus mo-
tif creates another layer of complexity in understanding
the principles underlying combinatorial regulation of tran-
scription. A number of TF families are known to be able
to accommodate diverse sets of binding sequences. Such
binding modes pose specific challenges for motif scanning
tools that rely on simple position weight matrices, which as-
sume positional independence, or on consensus k-mer pat-
terns from high-affinity sequence binders (67) or are too
divergent to be captured by probabilistic models such as
HMMs (68). Yet, given the critical roles of Sox and Pax TFs
to direct cell fate choices and the frequent co-occurrence
in the nuclei of diverse cell types, such unchartered non-
consensus target sites are likely fundamentally important.
Consistently, we detected eight novel target sites in human
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fore, an unbiased assessment of how TF partnerships influ-
ence DNA sequence preferences as well as an understand-
ing of the structural basis for DNA-induced allostery is re-
quired to decode how developmental programs are geneti-
cally hard-wired.
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